Sungwoong Kim, Ph.D., is a research scientist at UL Research Institutes’ Chemical Insights. He develops engineered organoid and tissue models that replicate human organ systems for toxicology studies, using three-dimensional environments and single-cell analysis to create alternatives to animal models. His research enables better evaluation of environmental exposures and supports human-centered public health strategies.

Sungwoong earned his Ph.D. in Materials Science and Engineering from Cornell University, focusing on T and B cell regulation through engineered microenvironments and gene editing. He completed postdoctoral training at Georgia Tech’s CMaT and Emory University, where he developed scalable CAR-T cell manufacturing platforms and established assays for studying alloimmunity and antibody responses. In the biopharmaceutical industry, he worked on lymphatic drug delivery systems, conducting preclinical studies and developing immunoassays for clinical application.

He has authored many peer-reviewed publications, holds two patents, and received the Immuno Delivery Focus Group Award from the Controlled Release Society.

ORCiD: 0000-0001-8585-4176